Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia-Reference-Cited by-同舟云学术

Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

Published:2017 Issue: Volume:7 Page:40-44
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Jain Prachi,Klotz Jeffrey,Dunavin Neil,Lu Kit,Koklanaris Eleftheria,Draper Debbie,Superata Jeanine,Chinian Fariba,Yu Quan,Keyvanfar Keyvan,Wong Susan,Muranski Pawel,Barrett A. John,Ito Sawa,Battiwalla Minoo

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference10 articles.

1. Treating the elderly patient with acute myelogenous leukemia;Luger;Hematol.: Am. Soc. Hematol. Educ. Program,2010

2. Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors;Kantarjian;J. Clin. Oncol.,2010

3. A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia;Fehniger;Blood,2011

4. Mechanisms of action of lenalidomide in B-cell non-hodgkin lymphoma;Gribben;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol.,2015

5. Immunomodulating drugs in myelodysplastic syndromes;Ades;Hematol./Am. Soc. Hematol. Educ. Program,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Power of Immune Microenvironment in AML Therapy: Current Insight and Future Prospects;Interdisciplinary Cancer Research;2024

2. Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects;Pathogens;2022-06-29

3. Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34+ Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia;Cancers;2021-01-07

4. Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment;Cancers;2020-09-05

5. Integrating the “Immunome” in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design;Journal of Clinical Oncology;2020-05-20